ACADIA Pharmaceuticals Inc. (ACAD) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin inverse agonist/antagonist for the treatment of…
Source: Yahoo Finance
Sector & Industry
ACADIA Pharmaceuticals Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
ACADIA Pharmaceuticals Inc. at a Glance
| Company | ACADIA Pharmaceuticals Inc. |
| Ticker | ACAD |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $28.02 |
| Market cap | $4.83B |
| P/E ratio (trailing) | 12.57 |
| EPS (trailing) | $2.23 |
| 52-week high | $30.96 |
| 52-week low | $19.69 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.86 |
| Return on equity (ROE) | 35.74% |
| Debt-to-equity | 5.65% |
| Average volume | 1.64M |
| Shares outstanding | 172.31M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 796 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is ACADIA Pharmaceuticals Inc.'s current P/E ratio?
- ACADIA Pharmaceuticals Inc. (ACAD) has a trailing P/E ratio of 12.57 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is ACADIA Pharmaceuticals Inc.'s market capitalisation?
- ACADIA Pharmaceuticals Inc.'s market cap is $4.83B based on our latest snapshot. See how it ranks by market cap →
- What is ACAD's 52-week range?
- Over the past 52 weeks, ACAD has traded between $19.69 and $30.96. What does the 52-week range mean? →
- How volatile is ACADIA Pharmaceuticals Inc. compared to the market?
- ACADIA Pharmaceuticals Inc. has a beta of 0.86, meaning it has historically moved less than the broader market. What does beta measure? →
- Does ACADIA Pharmaceuticals Inc. pay a dividend?
- ACADIA Pharmaceuticals Inc. does not currently pay a dividend according to our latest data.
- What exchange is ACAD listed on?
- ACAD is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is ACADIA Pharmaceuticals Inc. in?
- ACADIA Pharmaceuticals Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →